Protect Against Thrombus

The immediate establishment of a functional endothelial monolayer could reduce both the composition and the time period of anti-platelet regimens, especially as compared to the 3 to 12 months following drug eluting stent implantation. A partial list of patients and factors that could benefit from Genous’ accelerated natural healing to protect against thrombus are listed in the table below.

Patient who should not be on extended anti-platelet therapy High risk factors for subacute thrombosis (SAT)
  • Patients who may need to have surgery or major dental work in the near future
  • Patients who have gastrointestinal bleeding
  • Patients who have ulcers
  • Patients who have a history of noncompliance
  • Acute myocardial infarction (AMI)
  • Diabetes
  • Dissection
  • Cardiogenic shock
  • Long lesions
  • Small vessels
  • Multiple stents